Waraluck Chaichompoo

6PUBLICATIONS
31CO-AUTHORS
Biologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Structural modification of (‒)-xanthorrhizol isolated from Curcuma aromatica rhizomes to analogs with potent nitric oxide inhibitory activities.

|Jan 07, 2026
Dual COX-2 and EGFR inhibition by pyrazole-ar-turmerone hybrids suppresses colorectal cancer cell proliferation.

Monsin Sangsawat, Nonthaneth Nalinratana, Waraluck Chaichompoo

|Oct 29, 2025
Asiatic Acid from Centella asiatica as a Potent EGFR Tyrosine Kinase Inhibitor with Anticancer Activity in NSCLC Cells Harboring Wild-Type and T790M-Mutated EGFR.

Chaiwat Monmai, Sahachai Sabuakham, Wachirachai Pabuprapap

|May 02, 2023
Protective effects of Stephania pierrei tuber-derived oxocrebanine against LPS-induced acute lung injury in mice.

Wanatsanan Chulrik, Chutima Jansakun, Waraluck Chaichompoo

|Jul 13, 2022
Oxocrebanine from Stephania pierrei exerts macrophage anti-inflammatory effects by downregulating the NF-κB, MAPK, and PI3K/Akt signalling pathways.

Wanatsanan Chulrik, Chutima Jansakun, Waraluck Chaichompoo

|May 30, 2019
Synergistic effects of the capsaicinoid nonivamide and rosuvastatin on obesity-related endothelial dysfunction in rat fed a high-fat diet.

Sivanan Sivasinprasasn, Naruemon Wikan, Jiraporn Tocharus

Pageof 1

Frequent Collaborators

5 joint publications

Apichart Suksamrarn

3 joint publications

Warangkana Chunglok

2 joint publications

Wachirachai Pabuprapap

2 joint publications

Pornchai Rojsitthisak